Troutman Matthew D, Thakker Dhiren R
Division of Drug Delivery and Disposition, School of Pharmacy, The University of North Carolina at Chapel Hill, Chapel Hill, North Carolina 27599, USA.
Pharm Res. 2003 Aug;20(8):1210-24. doi: 10.1023/a:1025001131513.
The purpose of this work was to elucidate the asymmetric effect of P-gp on modulation of absorptive and secretory transport of compounds across polarized epithelium, to develop experimental parameters to quantify P-gp-mediated modulation of absorptive and secretory transport, and to elucidate how P-gp-mediated modulation of transport is affected by passive diffusion properties, interaction of the substrate with P-gp, and P-gp expression.
The permeability of a set of P-gp substrates was determined in absorptive and secretory directions in Madine-Darby Canine kidney (MDCK), Caco-2, and MDR-MDCK monolayers. The transport was also determined in the presence of GW918, a non-competitive P-gp inhibitor, to quantify the permeability without the influence of P-gp. From these two experimental permeability values in each direction, two new parameters, absorptive quotient (AQ) and the secretory quotient (SQ), were defined to express the functional activity of P-gp during absorptive and secretory transport, respectively. Western blot analysis was used to quantify P-gp expression in these monolayers and in normal human intestinal.
P-gp expression in Caco-2 and MDR-MDCK monolayers was comparable to that in normal intestine, and much less in MDCK cells. For all models, the substrates encompassed a wide range of apparent permeability due to passive diffusion (PPD). The parameters AQ and SQ, calculated for all compounds, assessed the attenuation in absorptive and enhancement of secretory transport, respectively, normalized to the permeability due to passive diffusion. Analysis of these parameters showed that 1) P-gp affected absorptive and secretory transport differentially and 2) compounds could be stratified into distinct groups with respect to the modulation of their absorptive and secretory transport by P-gp. Compounds could be identified whose absorptive transport was either strongly affected or poorly affected by changes in P-gp expression. For certain compounds, AQ values showed parabolic relationship with respect to passive diffusivity, and for others AQ was unaffected by changes in passive diffusivity.
The relationship between attenuation of absorptive transport and enhancement of secretory transport of compounds by P-gp is asymmetric, and different for different sets of compounds. The relationship between attenuation of absorption by P-gp and passive diffusivity of compounds, their interaction potential with P-gp, and levels of P-gp expression is complex; however, compounds can be classified into sets based on these relationships. A classification system that describes the functional activity of P-gp with respect to modulation of absorptive and secretory transport was developed from these results.
本研究旨在阐明P-糖蛋白(P-gp)对化合物跨极化上皮细胞吸收和分泌转运调节的不对称效应,建立用于量化P-gp介导的吸收和分泌转运调节的实验参数,并阐明P-gp介导的转运调节如何受到被动扩散特性、底物与P-gp的相互作用以及P-gp表达的影响。
在犬肾Madine-Darby(MDCK)、人结肠腺癌细胞(Caco-2)和多药耐药MDCK(MDR-MDCK)单层细胞中,测定一组P-gp底物在吸收和分泌方向的通透性。在非竞争性P-gp抑制剂GW918存在的情况下也测定转运情况,以量化不受P-gp影响的通透性。根据每个方向上的这两个实验通透性值,定义了两个新参数,即吸收商(AQ)和分泌商(SQ),分别用于表示P-gp在吸收和分泌转运过程中的功能活性。采用蛋白质免疫印迹分析来量化这些单层细胞和正常人体肠道中P-gp的表达。
Caco-2和MDR-MDCK单层细胞中P-gp的表达与正常肠道中的相当,而在MDCK细胞中则少得多。对于所有模型,由于被动扩散(PPD),底物的表观通透性范围很广。为所有化合物计算的AQ和SQ参数分别评估了吸收转运的衰减和分泌转运的增强,并以被动扩散引起的通透性进行归一化。对这些参数的分析表明:1)P-gp对吸收和分泌转运的影响不同;2)就P-gp对其吸收和分泌转运的调节而言,化合物可分为不同的组。可以鉴定出其吸收转运受P-gp表达变化强烈影响或影响较小的化合物。对于某些化合物,AQ值与被动扩散系数呈抛物线关系,而对于其他化合物,AQ不受被动扩散系数变化的影响。
P-gp对化合物吸收转运的衰减和分泌转运的增强之间的关系是不对称的,且因化合物组的不同而不同。P-gp介导的吸收衰减与化合物的被动扩散系数、它们与P-gp的相互作用潜力以及P-gp表达水平之间的关系很复杂;然而,化合物可以根据这些关系进行分类。基于这些结果,开发了一种描述P-gp在调节吸收和分泌转运方面功能活性的分类系统。